18 August 2021: Clinical Research
Effects of Doxofylline Combined with Ceftazidime on Clinical Efficacy, Drug Safety, and Prognosis in Patients with Chronic Obstructive Pulmonary Disease Complicated with Infection
Ruijing Yan ABCD , Ying Wang EFG*DOI: 10.12659/MSM.930494
Med Sci Monit 2021; 27:e930494
Table 1 Comparison of patients’ general information.
| Group | Case | Male (n, %) | Female (n, %) | Average age (year) | Average disease course (year) |
|---|---|---|---|---|---|
| Control group | 225 | 109 (48.44) | 116 (51.56) | 62.45±11.02 | 10.57±9.46 |
| Observation group | 225 | 117 (52.00) | 108 (48.00) | 62.34±10.87 | 10.66±9.25 |
| Blank group | 50 | 33 (66.00) | 27 (54.00) | 60.28±8.31 | 9.17±7.39 |
| χ/ value | 1.053 | 0.883 | 0.563 | ||
| value | 0.591 | 0.414 | 0.570 | ||